Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IVTY

Invuity (IVTY) Stock Price, News & Analysis

Invuity logo

About Invuity Stock (NASDAQ:IVTY)

Advanced Chart

Key Stats

Today's Range
$7.39
$7.39
50-Day Range
N/A
52-Week Range
$2.35
$9.55
Volume
N/A
Average Volume
324,995 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IVTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invuity and its competitors with MarketBeat's FREE daily newsletter.

IVTY Stock News Headlines

Ivy Bank Review: Solid High-Interest Savings
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Delaware Ivy Large Cap Growth Fund A
CLPS Inc (CLPS)
Bruce A Cleveland's Net Worth
See More Headlines

IVTY Stock Analysis - Frequently Asked Questions

Invuity, Inc. (NASDAQ:IVTY) posted its quarterly earnings data on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.10. The medical instruments supplier had revenue of $10.50 million for the quarter, compared to the consensus estimate of $10.73 million.

Invuity (IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at a price of $12.00 per share. Piper Jaffray, Leerink Partners and Stifel acted as the underwriters for the IPO and William Blair was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invuity investors own include Cornerstone Strategic Investment Fund (CLM), Allena Pharmaceuticals (ALNA), Madrigal Pharmaceuticals (MDGL), Mondi (MNDI), Protalix BioTherapeutics (PLX), SELLAS Life Sciences Group (SLS) and Spero Therapeutics (SPRO).

Company Calendar

Last Earnings
8/02/2018
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IVTY
CIK
1393020
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:IVTY) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners